Advantages of OCT

Article

According to Professor Albert Augustin, OCT is mandatory in research and very helpful in avoiding unnecessary treatment.

According to Professor Albert Augustin, OCT is mandatory in research and very helpful in avoiding unnecessary treatment. He described his viewpoint in this month's cover feature on retina imaging.

"One of the major advantages of SD-OCT is the ability to create 3D samples of the tissue…" Prof. Augustin said. This enables more insight and better understanding as much more detail can be seen.

Not only can OCT technology assist in a surgeons preoperative judgement of a patient but it can also help with the decision on treatment regimen. In planning surgery a physician can use SD-OCT to perform a correct prognosis on a patient as it will allow them to view any alterations occurring, for example, in the RPE. Once the correct prognosis has been made then the level of detail gained form an OCT image can be used to guide the practitioner to the appropriate procedure.

Surgical follow-up of a patient can also benefit from OCT. In cases of retinal vein occlusion it is possible to view bright reflective dots that are inflammatory markers that should react on the implantation of dexamethasone slow release devices. "Differences in the numbers of these dots can be assessed by OCT during the follow up of a RVO patient," said Prof. Augustin.

OCT is interesting in research and clinical follow up in Prof. Augustin's opinion. However, he stressed that in cases of AMD OCT is mandatory and the images must be viewed carefully. It is simple to misinterpret results leading to an incorrect diagnosis and mistreatment of patients.

In conclusion, Prof. Augustin said, "I would like to encourage the use of OCT, especially in macular disesases."

If you would like to read more about the advantages of OCT, see Prof. Augustin's full article in the May print issue of OTEurope.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.